Top Markets
Coin of the day
Nicox S.A. Nicox S.A.

Nicox S.A.

COX
Kedudukan dalam Saham #34243
Nicox S.A. is an ophthalmology enterprise operating both within France and... Nicox S.A. is an ophthalmology enterprise operating both within France and globally, focused on developing therapies to safeguard vision and enhance overall eye health. Its leading investigational drug, NCX 470, an innovative nitric oxide-donating prostaglandin analog designed to decrease intraocular pressure in individuals with open-angle glaucoma or ocular hypertension, is currently undergoing Phase 3 clinical trials. Furthermore, the company is progressing NCX 4251, a specialized fluticasone formulation, through a Phase 2b clinical trial for the management of acute exacerbations of blepharitis, as well as NCX 1728. Nicox also provides VYZULTA, a latanoprostene bunod ophthalmic solution for treating open-angle glaucoma or ocular hypertension, and ZERVIATE, a cetirizine ophthalmic solution to relieve ocular itching related to allergic conjunctivitis. The company, established in 1996, has its main office situated in Valbonne, France.
Harga Saham
$0.6379482
Disegerakkan terakhir: 2023-05-22
Modal Pasaran
$5.98M
Perubahan (1 hari)
-0.44%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Nicox S.A. (COX)

Kategori

Sejarah harga saham bagi Nicox S.A. (COX)
Harga penutupan tertinggi: $0.65 pada 2023-05-01

Harga penutupan terendah: $102.25 pada 2000-04-01
Sejarah harga saham Nicox S.A. dari 2000 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2023 -48.08%
2022 -59.00%
2021 -42.67%
2020 16.87%
2019 -16.61%
2018 -54.28%
2017 42.86%
2016 -2.69%
2015 -28.86%
2014 -26.67%
2013 9.02%
2012 130.59%
2011 -56.02%
2010 -64.73%
2009 -17.78%
2008 -31.69%
2007 -41.28%
2006 626.06%
2005 -20.50%
2004 16.34%
2003 -70.85%
2002 5.93%
2001 -38.42%
2000 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE